AU2003205627A1 - Diagnostics and therapeutics for diseases associated with gpr72 - Google Patents

Diagnostics and therapeutics for diseases associated with gpr72

Info

Publication number: AU2003205627A1
Authority: AU; Australia
Prior art keywords: gpr72; therapeutics; diagnostics; diseases associated; diseases
Prior art date: 2002-02-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003205627A

Inventor

Ulf Bruggemeier

Andreas Geerts

Stefan Golz

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer AG

Original Assignee

Bayer Healthcare AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-01

Filing date

2003-01-20

Publication date

2003-09-02

2003-01-20 Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG

2003-09-02 Publication of AU2003205627A1 publication Critical patent/AU2003205627A1/en

Status Abandoned legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Hematology (AREA)
Neurology (AREA)
Food Science & Technology (AREA)
Pulmonology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Microbiology (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU2003205627A 2002-02-01 2003-01-20 Diagnostics and therapeutics for diseases associated with gpr72 Abandoned AU2003205627A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP02001941.0		2002-02-01
EP02001941		2002-02-01
PCT/EP2003/000476 WO2003065044A2 (en)	2002-02-01	2003-01-20	Diagnostics and therapeutics for diseases associated with gpr72

Publications (1)

Publication Number	Publication Date
AU2003205627A1 true AU2003205627A1 (en)	2003-09-02

Family

ID=27635779

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003205627A Abandoned AU2003205627A1 (en)	2002-02-01	2003-01-20	Diagnostics and therapeutics for diseases associated with gpr72

Country Status (2)

Country	Link
AU (1)	AU2003205627A1 (en)
WO (1)	WO2003065044A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007035551A1 (en) *	2005-09-19	2007-03-29	Eisai R & D Management Co., Ltd.	Methods for identifying gpr83 agonists and antagonists capable of modulating regulatory t cell function
EP1867994B1 (en) *	2006-06-13	2012-09-26	Euroscreen S.A.	Ligand for G-protein coupled receptor GPR72 and uses thereof
CA2589393C (en)	2006-06-13	2016-04-12	Euroscreen S.A.	Ligand for g-protein coupled receptor gpr72 and uses thereof
US20090280092A1 (en) *	2007-01-22	2009-11-12	Wiebke Hansen	G-Protein Coupled Receptor 83 As a Molecular Switch for the Induction of Regulatory (immunosuppressive) T-cells
ES2825718T3 (en)	2007-02-01	2021-05-17	Univ Der Johannes Gutenberg Univ Mainz	Specific activation of a regulatory T cell and its use for the treatment of asthma, allergic diseases, autoimmune diseases, graft rejection and for the induction of tolerance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1165147A (en) *	1996-02-07	1997-11-19	武田药品工业株式会社	Guanine nudeotide combined protein coupled receptor proteins, their production and use
CA2231754A1 (en) *	1997-05-07	1998-11-07	Smithkline Beecham Corporation	A novel human g-protein coupled receptor hcept09
SE9904660D0 (en) *	1999-12-17	1999-12-17	Astra Pharma Inc	Novel assays

2003
- 2003-01-20 AU AU2003205627A patent/AU2003205627A1/en not_active Abandoned
- 2003-01-20 WO PCT/EP2003/000476 patent/WO2003065044A2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2003065044A8 (en)	2003-12-24
WO2003065044A3 (en)	2004-03-04
WO2003065044A2 (en)	2003-08-07

Similar Documents

Publication	Publication Date	Title
AU2003289716A1 (en)	2004-04-30	Molecules for diagnostics and therapeutics
AU2003281505A1 (en)	2004-02-09	Chair
AU2003236211A1 (en)	2003-10-27	Smac-peptides as therapeutics against cancer and autoimmune diseases
AU2003301894A1 (en)	2004-06-07	Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d)
AU2003276220A1 (en)	2004-06-03	Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a)
AU2003229735A1 (en)	2003-11-17	Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
AU2003210518A1 (en)	2003-09-02	Molecules for diagnostics and therapeutics
AU2003205627A1 (en)	2003-09-02	Diagnostics and therapeutics for diseases associated with gpr72
AU2003276136A1 (en)	2004-06-07	Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1)
AU2003206749A1 (en)	2003-09-02	Diagnostics and therapeutics for diseases associated with the gpr65 receptor
AU2003239589A1 (en)	2003-12-12	Eta-1 gene and methods for use
AU2003283427A1 (en)	2004-06-30	Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1)
AU2003283303A1 (en)	2004-06-07	Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b)
AU2003294728A1 (en)	2004-06-30	DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2)
AU2003279361A1 (en)	2004-06-03	DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b)
AU2003267380A1 (en)	2004-04-19	Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a)
AU2003245981A1 (en)	2004-01-19	Diagnostics and therapeutics for diseases associated with the g2a-receptor (g2a)
AU2003274083A1 (en)	2004-06-07	Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a)
AU2003218638A1 (en)	2003-09-02	Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
AU2003289894A1 (en)	2004-06-30	Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4)
AU2003241466A1 (en)	2004-11-26	Surface-covering system and methods for making and using the same
AU2003241937A1 (en)	2003-12-22	Examination chair
AU2003229736A1 (en)	2003-11-17	Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1)
AU2003288171A1 (en)	2004-06-30	Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a3 (pde9a3)
AU2003295504A1 (en)	2004-06-07	Development of therapeutics for the treatment of endotoxin-mediated diseases

Legal Events

Date	Code	Title	Description
2004-10-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase